21 Aug 2021

The Lasting Impact of COVID-19 on Drug Development

A disrupter event to many businesses and industries worldwide, what lasting impacts will be felt and what can pharma learn from the COVID-19 pandemic in terms of the acceleration of drug development and repurposing in the future; the broader impact on how trials are conducted, and the impact of virtual clinical trials for clinical supplies business.

Discussion Points
  • Fast-tracking R&D
  • Emergency use approvals
  • Drug Repurposing
  • Diversifying Clinical trials
  • This session was originally broadcast live as part of CPhI North America 2021

    Content provided by our supplier

    Thermo Fisher Scientific Inc.

    • US
    • 2015
      On CPhI since
    • 5000+

    Other Content from Thermo Fisher Scientific Inc.